ACCENDRA HEALTH INC/VA/ - Common Stock, $2 par value per share (OMI) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock, $2 par value per share
Symbol
OMI on NYSE
Shares outstanding
77,519,568
Price per share
$2.80
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
72,664,978
Total reported value
$348,916,915
% of total 13F portfolios
0%
Share change
-2,439,166
Value change
-$36,723,823
Number of holders
197
Price from insider filings
$2.80
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ACCENDRA HEALTH INC/VA/ - Common Stock, $2 par value per share (OMI) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Coliseum Capital Management, LLC 17% +12% $62,883,874 +$7,381,690 13,100,807 +13% Coliseum Capital Management, LLC 12 Nov 2025
VANGUARD GROUP INC 7.7% $28,621,666 5,962,847 The Vanguard Group 30 Sep 2025
BlackRock, Inc. 7.1% -51% $29,888,199 -$32,238,791 5,454,051 -52% BlackRock, Inc. 30 Sep 2025
DIMENSIONAL FUND ADVISORS LP 4.5% $16,836,283 3,507,559 Dimensional Fund Advisors LP 30 Sep 2025
FMR LLC 3.5% -50% $19,031,279 -$21,607,348 2,718,754 -53% FMR LLC 31 Mar 2025

As of 30 Sep 2025, 197 institutional investors reported holding 72,664,978 shares of ACCENDRA HEALTH INC/VA/ - Common Stock, $2 par value per share (OMI). This represents 94% of the company’s total 77,519,568 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of ACCENDRA HEALTH INC/VA/ - Common Stock, $2 par value per share (OMI) together control 77% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Coliseum Capital Management, LLC 17% 13,100,807 +13% 6.1% $62,883,874
VANGUARD GROUP INC 7.7% 5,962,847 -26% 0% $28,621,666
BlackRock, Inc. 7.2% 5,613,838 -48% 0% $26,946,422
DIMENSIONAL FUND ADVISORS LP 4.5% 3,507,559 -18% 0% $16,835,489
MILLENNIUM MANAGEMENT LLC 4.2% 3,261,254 +192% 0.01% $15,654,019
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 4.1% 3,208,915 +4.3% 0% $15,402,792
Invenomic Capital Management LP 3.5% 2,749,122 0.69% $13,195,786
PARADIGM CAPITAL MANAGEMENT INC/NY 3.4% 2,611,600 +32% 0.54% $12,535,680
D. E. Shaw & Co., Inc. 3% 2,319,984 +62% 0.01% $11,135,923
STATE STREET CORP 2.5% 1,964,536 -36% 0% $9,429,773
CITADEL ADVISORS LLC 2.4% 1,893,777 +523% 0.01% $9,090,129
MORGAN STANLEY 2.1% 1,601,058 +43% 0% $7,685,084
GEODE CAPITAL MANAGEMENT, LLC 1.9% 1,460,801 -18% 0% $7,013,071
JANE STREET GROUP, LLC 1.7% 1,332,397 0.01% $6,395,506
Dana Investment Advisors, Inc. 1.6% 1,265,560 +24% 0.18% $6,074,688
TOWLE & CO 1.6% 1,247,959 +73% 1.5% $5,990,203
TWO SIGMA INVESTMENTS, LP 1.4% 1,059,371 +51% 0.01% $5,084,981
Connor, Clark & Lunn Investment Management Ltd. 1.2% 926,979 -7.4% 0.01% $4,449,499
NORTHERN TRUST CORP 0.93% 718,698 -22% 0% $3,449,751
Empowered Funds, LLC 0.92% 716,184 +91% 0.03% $3,437,683
HRT FINANCIAL LP 0.92% 711,684 +634% 0.01% $3,416,000
GOLDMAN SACHS GROUP INC 0.9% 696,791 +94% 0% $3,344,596
RENAISSANCE TECHNOLOGIES LLC 0.89% 690,800 -19% 0% $3,315,840
BANK OF AMERICA CORP /DE/ 0.77% 598,663 +169% 0% $2,873,583
BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.77% 598,358 -0.13% 0.06% $2,872,118

Institutional Holders of ACCENDRA HEALTH INC/VA/ - Common Stock, $2 par value per share (OMI) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 110,168 $298,853 +$37,709 $2.80 7
2025 Q3 72,664,978 $348,916,915 -$36,723,823 $4.80 197
2025 Q2 74,911,798 $681,593,001 +$6,794,289 $9.10 232
2025 Q1 74,234,901 $669,904,713 -$41,362,354 $9.03 242
2024 Q4 75,999,825 $993,410,302 -$18,686,473 $13.07 196
2024 Q3 76,365,231 $1,197,927,357 +$1,856,856 $15.69 213
2024 Q2 77,398,830 $1,045,066,388 -$17,380,767 $13.50 221
2024 Q1 77,199,314 $2,139,054,036 +$26,197,352 $27.71 224
2023 Q4 206,701 $3,983,128 +$1,440,278 $19.27 3
2023 Q3 79,858,116 $1,290,561,342 +$95,776,425 $16.16 205
2023 Q2 74,529,900 $1,419,135,822 +$9,529,628 $19.04 223
2023 Q1 74,092,292 $1,077,976,440 -$30,734,101 $14.55 212
2022 Q4 75,383,588 $1,472,282,410 -$32,149,920 $19.53 209
2022 Q3 75,453,751 $1,818,625,678 -$61,404,133 $24.10 207
2022 Q2 78,503,403 $2,463,048,099 +$39,445,731 $31.45 239
2022 Q1 77,035,957 $3,391,591,368 +$216,131,408 $44.02 255
2021 Q4 72,003,396 $3,132,242,501 -$84,643,395 $43.50 262
2021 Q3 71,398,337 $2,234,602,466 +$61,408,724 $31.29 241
2021 Q2 68,073,762 $2,880,861,652 +$140,775,935 $42.33 255
2021 Q1 65,614,369 $2,466,057,454 -$3,321,762 $37.59 251
2020 Q4 63,767,387 $1,724,988,583 +$289,029,355 $27.05 223
2020 Q3 54,478,221 $1,363,467,183 -$12,475,330 $25.11 198
2020 Q2 56,144,429 $427,735,951 +$3,966,896 $7.62 178
2020 Q1 54,982,885 $502,996,182 -$1,714,056 $9.15 168
2019 Q4 56,887,308 $294,142,891 +$4,985,624 $5.17 168
2019 Q3 55,189,243 $320,629,234 +$10,242,133 $5.81 161
2019 Q2 51,405,024 $164,321,638 -$4,003,276 $3.20 148
2019 Q1 46,093,405 $188,963,720 -$19,482,453 $4.10 166
2018 Q4 58,472,510 $370,278,264 +$5,417,859 $6.33 193
2018 Q3 55,676,772 $919,692,202 -$4,834,554 $16.52 206
2018 Q2 56,474,648 $943,754,147 -$371,499 $16.71 223
2018 Q1 55,967,944 $871,131,956 -$52,821,168 $15.55 234
2017 Q4 59,728,438 $1,127,827,881 -$64,448,450 $18.88 224
2017 Q3 60,415,740 $1,764,541,165 -$14,562,620 $29.20 254
2017 Q2 60,284,613 $1,940,490,185 -$13,134,451 $32.19 268
2017 Q1 61,034,097 $2,111,738,210 +$334,882,776 $34.60 276
2016 Q4 58,378,466 $2,060,316,952 -$3,558,429 $35.29 277
2016 Q3 58,602,074 $2,032,518,625 -$109,250,439 $34.73 280
2016 Q2 61,439,045 $2,296,427,944 -$64,344,175 $37.38 276
2016 Q1 60,560,521 $2,447,715,349 -$5,564,990 $40.42 281
2015 Q4 62,490,192 $2,248,637,214 -$68,584,661 $35.98 262
2015 Q3 65,318,059 $2,086,336,977 +$75,228,540 $31.94 244
2015 Q2 61,046,558 $2,075,687,595 +$52,282,123 $34.00 234
2015 Q1 61,095,105 $2,067,770,810 +$80,005,922 $33.84 229
2014 Q4 58,668,292 $2,059,982,972 -$61,570,958 $35.11 224
2014 Q3 60,478,214 $1,980,104,575 -$39,186,136 $32.74 217
2014 Q2 61,498,409 $2,089,731,972 -$14,549,323 $33.98 236
2014 Q1 60,780,139 $2,129,071,381 -$25,977,829 $35.03 237